ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 130 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $38,000 | – | 23,000 | +11286.1% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 202 | -76.8% | 0.00% | – |
| Q4 2015 | $1,000 | 0.0% | 872 | +30.1% | 0.00% | – |
| Q3 2015 | $1,000 | -96.6% | 670 | +15.5% | 0.00% | -100.0% |
| Q2 2015 | $29,000 | -31.0% | 580 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $42,000 | -90.6% | 580 | -99.3% | 0.00% | -88.9% |
| Q3 2014 | $449,000 | -35.2% | 80,600 | -0.4% | 0.01% | -30.8% |
| Q4 2013 | $693,000 | +317.5% | 80,960 | +588.0% | 0.01% | +333.3% |
| Q3 2013 | $166,000 | +232.0% | 11,768 | +246.5% | 0.00% | +200.0% |
| Q2 2013 | $50,000 | – | 3,396 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $5,085,000 | 1.68% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,369,066 | $25,603,000 | 1.03% |
| Lyons Wealth Management, LLC. | 56,775 | $334,000 | 0.30% |
| Callan Capital, LLC | 66,118 | $387,000 | 0.10% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 383,050 | $2,245,000 | 0.06% |
| FCG ADVISORS, LLC | 10,600 | $62,000 | 0.05% |
| OppenheimerFunds, Inc. | 7,000,000 | $41,020,000 | 0.04% |
| NEXT Financial Group, Inc | 19,704 | $86,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 27,893,387 | $163,455,000 | 0.04% |
| MURPHY CAPITAL MANAGEMENT INC | 45,000 | $263,000 | 0.04% |